{"id":"W4307775795","doi":"10.1684/ejd.2022.4280","title":"Improvement of head and neck symptoms in patients with atopic dermatitis treated with baricitinib with in five Phase III clinical trials","year":2022,"lang":"en","type":"article","venue":"European Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"EMD Serono; LEO Pharma; Kyowa Hakko Kirin; Sanofi Genzyme; Incyte; Kiniksa Pharmaceuticals; Kyowa Kirin Pharmaceutical Development; Dermira; Regeneron Pharmaceuticals; Sanofi; Oregon Health and Science University; Les Laboratories Pierre Fabre; Celgene; Amgen; Pfizer; Galderma; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Atopic dermatitis; Head and neck; Dermatology; Clinical trial; Surgery; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007085978,0.0001818078,0.001249451,0.0003479128,0.00005698192,0.000006754331,0.0001263065,0.00003521765,0.00007634264],"category_scores_gemma":[0.0001558068,0.0001170225,0.00007385366,0.0002532633,0.0002413886,0.00009584867,0.00005856197,0.0004818837,0.000001112012],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000322436,"about_ca_system_score_gemma":0.0001744971,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009770657,"about_ca_topic_score_gemma":0.00001436059,"domain_scores_codex":[0.9959233,0.001814782,0.001564608,0.0001974162,0.0002635723,0.0002363161],"domain_scores_gemma":[0.9981949,0.0003283583,0.0009981102,0.0001747971,0.0001379454,0.0001658606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008132194,0.001741425,0.9734813,0.00006777977,0.0003063577,0.01073055,0.0004530993,0.00001677489,0.000005819789,0.00001459955,0.0005338004,0.004516276],"study_design_scores_gemma":[0.09046394,0.006998385,0.8952931,0.0003166877,0.0002659275,0.00558284,0.0004021566,0.00003833283,0.000104938,0.000007166081,0.0004001245,0.0001264556],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997881,0.0004377997,0.0000443709,0.0006660807,0.00005077305,0.0004472808,0.00001818826,0.00000736098,0.0004471499],"genre_scores_gemma":[0.9989998,0.00003560169,0.0001822295,0.0006939635,0.00001661518,0.000007427526,0.00002380964,0.00002338044,0.00001712235],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08233175,"threshold_uncertainty_score":0.4772039,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02310291459643472,"score_gpt":0.3195896760651961,"score_spread":0.2964867614687614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}